Centrexion competitorsClear all

Centrexion's top competitors include Odonate Therapeutics, Goldfinch Bio, Ginkgo Bioworks and Verona Pharma.

Save Comparison	Centrexion Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.	Odonate Therapeutics Odonate Therapeutics is dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer.	Goldfinch Bio Goldfinch is singularly focused on discovering and developing precision therapies for patients with kidney disease.	Ginkgo Bioworks Ginkgo Bioworks is a company that designs, engineers, develops, tests, and licenses organisms.	Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Founding Date	Founding Date 2013	Founding Date 2016	Founding Date N/A	Founding Date 2008	Founding Date N/A
Type	Type Public	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Boston, US HQ Baltimore, US	Locations San Diego, US HQ	Locations Cambridge, US HQ	Locations Boston, US HQ	Locations London, GB HQ Cardiff, GB Raleigh, US
Employees	Employees 274% increase	Employees 21	Employees N/A	Employees 3746% increase	Employees 33
Valuation ($)	Valuation ($) N/A	Valuation ($) 561.8 m	Valuation ($) N/A	Valuation ($) 4 b	Valuation ($) N/A
Twitter followers	Twitter followers 240	Twitter followers N/A	Twitter followers N/A	Twitter followers 84	Twitter followers N/A
Alexa Website Rank	Alexa Website Rank 756111	Alexa Website Rank 493048	Alexa Website Rank 393500	Alexa Website Rank 172938	Alexa Website Rank 320626
Employee Rating	Employee Rating N/A	Employee Rating 3.1	Employee Rating N/A	Employee Rating 4.8	Employee Rating N/A
Financial
Net income	Net income ($24.7m) (FY, 2017)	Net income ($111.8m) (FY, 2019)	Net income N/A	Net income N/A	Net income (£19.9m) (FY, 2018)
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 100m (3 months ago)	Latest funding round $ 70m (4 months ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 136.1m	Total funding raised N/A	Total funding raised $ 155m	Total funding raised $ 789.1m	Total funding raised $ 11.5m